Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week Low Following Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price hit a new 52-week low during mid-day trading on Wednesday after KeyCorp lowered their price target on the stock from $35.00 to $30.00. KeyCorp currently has an overweight rating on the stock. Acadia Healthcare traded as low as $14.94 and last traded at $15.01, with a volume of 3517513 shares traded. The stock had previously closed at $15.65.

Several other research firms have also recently issued reports on ACHC. Royal Bank Of Canada decreased their target price on shares of Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. UBS Group decreased their price target on shares of Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Cantor Fitzgerald dropped their price objective on Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Finally, Barclays lowered their price target on Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating for the company in a research report on Thursday, November 6th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has an average rating of “Moderate Buy” and an average price target of $32.36.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently modified their holdings of ACHC. Caxton Associates LLP bought a new position in shares of Acadia Healthcare during the first quarter worth about $394,000. Envestnet Portfolio Solutions Inc. raised its stake in Acadia Healthcare by 256.4% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after buying an additional 18,742 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in Acadia Healthcare by 85.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock worth $651,000 after buying an additional 13,188 shares during the last quarter. Janney Montgomery Scott LLC acquired a new position in shares of Acadia Healthcare in the 2nd quarter worth approximately $479,000. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock valued at $202,000 after acquiring an additional 622 shares during the last quarter.

Acadia Healthcare Stock Performance

The company has a 50-day moving average of $22.28 and a 200-day moving average of $22.45. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of 9.50, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.